We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Brain Cancer

Journal Scan / Research · September 30, 2021

A Framework for Sequencing Therapy in Grade II IDH-Mutant Gliomas

Cancer Research


Additional Info

Cancer Research
Mathematical Modeling and Mutational Analysis Reveal Optimal Therapy to Prevent Malignant Transformation in Grade II IDH-Mutant Gliomas
Cancer Res 2021 Sep 15;81(18)4861-4873, K Aoki, H Suzuki, T Yamamoto, KN Yamamoto, S Maeda, Y Okuno, M Ranjit, K Motomura, F Ohka, K Tanahashi, M Hirano, T Nishikawa, H Shimizu, Y Kitano, J Yamaguchi, S Yamazaki, H Nakamura, M Takahashi, Y Narita, M Nakada, S Deguchi, M Mizoguchi, Y Momii, Y Muragaki, T Abe, J Akimoto, T Wakabayashi, R Saito, S Ogawa, H Haeno, A Natsume

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading